Nomograms for predicting the survival rate for cervical cancer patients who undergo radiation therapy: a SEER analysis

Future Oncol. 2019 Sep;15(26):3033-3045. doi: 10.2217/fon-2019-0029. Epub 2019 Aug 27.

Abstract

Aim: To integrate multiple independent risk factors to establish prognostic nomograms for better predicting overall survival and disease-specific survival in patients with cervical cancer receiving radiation therapy. Materials & methods: Cox analysis used to construct nomograms. The C-index, time-dependent receiver operating characteristic and calibration plots were used to evaluate the performance. The discrimination abilities were compared using the decision curve analysis, net reclassification improvement and integrated discrimination improvement. Results: After randomization, 2869 and 1230 cervical cancer patients were included in the training and validation sets, respectively. Nomograms that incorporated all of the significant independent factors for predicting the 3- and 5-year overall survival and disease-specific survival in the training cohort were established. Conclusion: Compared with the International Federation of Gynecology and Obstetrics staging system, the proposed nomograms exhibit superior prognostic discrimination and survival prediction.

Keywords: FIGO stage; SEER; cervical cancer; nomogram; radiation therapy; survival.

MeSH terms

  • Disease Management
  • Female
  • Humans
  • Neoplasm Grading
  • Neoplasm Staging
  • Nomograms
  • Prognosis
  • Proportional Hazards Models
  • Reproducibility of Results
  • SEER Program
  • Sensitivity and Specificity
  • Survival Rate
  • Uterine Cervical Neoplasms / diagnosis
  • Uterine Cervical Neoplasms / mortality*
  • Uterine Cervical Neoplasms / radiotherapy*